James Mulshine to Biomarkers, Tumor
This is a "connection" page, showing publications James Mulshine has written about Biomarkers, Tumor.
Connection Strength
1.836
-
Lung cancer chemoprevention: moving from concept to a reality. Lung Cancer. 2003 Aug; 41 Suppl 1:S163-74.
Score: 0.193
-
IV international conference on prevention and early detection of lung cancer, Reykjavik, Iceland, August 9-12, 2001. Lung Cancer. 2002 Sep; 37(3):325-44.
Score: 0.181
-
Differential expression of the early lung cancer detection marker, heterogeneous nuclear ribonucleoprotein-A2/B1 (hnRNP-A2/B1) in normal breast and neoplastic breast cancer. Breast Cancer Res Treat. 2001 Apr; 66(3):217-24.
Score: 0.164
-
Considerations in developing successful, population-based molecular screening and prevention of lung cancer. Cancer. 2000 Dec 01; 89(11 Suppl):2465-7.
Score: 0.161
-
Peptide amidating activity in human bronchoalveolar lavage fluid. Lung Cancer. 1996 Jun; 14(2-3):239-51.
Score: 0.118
-
Molecular markers in early cancer detection. New screening tools. Chest. 1995 Jun; 107(6 Suppl):280S-286S.
Score: 0.110
-
Scientific basis for cancer prevention. Intermediate cancer markers. Cancer. 1993 Aug 01; 72(3 Suppl):978-83.
Score: 0.097
-
Early detection of lung cancer. Semin Oncol. 1993 Aug; 20(4):374-82.
Score: 0.097
-
Considerations in bringing a cancer biomarker to clinical application. Cancer Res. 1992 May 01; 52(9 Suppl):2711s-2718s.
Score: 0.089
-
Candidate biomarkers for application as intermediate end points of lung carcinogenesis. J Cell Biochem Suppl. 1992; 16G:183-6.
Score: 0.087
-
A subset of in situ breast tumor cell clusters lacks expression of proliferation and progression related markers but shows signs of stromal and vascular invasion. Cancer Detect Prev. 2005; 29(4):323-31.
Score: 0.053
-
Expression of early lung cancer detection marker: hnRNP-A2/B1 and its relation to microsatellite alteration in non-small cell lung cancer. Lung Cancer. 2001 Dec; 34(3):341-50.
Score: 0.043
-
Inhaled isotretinoin (13-cis retinoic acid) is an effective lung cancer chemopreventive agent in A/J mice at low doses: a pilot study. Clin Cancer Res. 2000 Aug; 6(8):3015-24.
Score: 0.039
-
Prospects for lung-cancer screening. Lancet. 2000 Feb 19; 355(9204):592-3.
Score: 0.038
-
Reducing lung cancer risk: early detection. Chest. 1999 Dec; 116(6 Suppl):493S-496S.
Score: 0.037
-
Expression of heterogeneous nuclear ribonucleoprotein A2/B1 in bronchial epithelium of chronic smokers. Clin Cancer Res. 1998 Jul; 4(7):1631-40.
Score: 0.034
-
Sputum screening by quantitative microscopy: a new dawn for detection of lung cancer? Mayo Clin Proc. 1997 Aug; 72(8):788-90.
Score: 0.032
-
Recent molecular advances in the approach to early lung cancer detection and intervention. Environ Health Perspect. 1997 Jun; 105 Suppl 4:935-9.
Score: 0.031
-
Expression of early lung cancer detection marker p31 in neoplastic and non-neoplastic respiratory epithelium. Lung Cancer. 1996 Feb; 14(1):85-97.
Score: 0.029
-
The early detection of second primary lung cancers by sputum immunostaining. LCEWDG Investigators. Lung Cancer Early Detection Group. Chest. 1994 Dec; 106(6 Suppl):385S-390S.
Score: 0.026
-
Monoclonal antibodies for early cytologic detection of lung cancer. Semin Thorac Cardiovasc Surg. 1993 Jul; 5(3):201-9.
Score: 0.024
-
Prospective trial evaluating immunocytochemical-based sputum techniques for early lung cancer detection: assays for promotion factors in the bronchial lavage. J Cell Biochem Suppl. 1993; 17F:175-83.
Score: 0.023
-
Rational targets for the early detection of lung cancer. J Natl Cancer Inst Monogr. 1992; (13):183-90.
Score: 0.022
-
Lung cancer: rational strategies for early detection and intervention. Oncology (Williston Park). 1991 May; 5(5):25-32; discussion 32-3, 37.
Score: 0.021
-
The use of volumetric CT as an imaging biomarker in lung cancer. Acad Radiol. 2010 Jan; 17(1):100-6.
Score: 0.019
-
Biological, molecular, and clinical markers for the diagnosis and typing of lung cancer. Immunol Ser. 1990; 53:453-68.
Score: 0.019
-
Neuroendocrine differentiation in endocrine and nonendocrine lung carcinomas. Am J Clin Pathol. 1988 Dec; 90(6):641-52.
Score: 0.017
-
Expression of neuroendocrine cell markers L-dopa decarboxylase, chromogranin A, and dense core granules in human tumors of endocrine and nonendocrine origin. Cancer Res. 1988 Jul 15; 48(14):4078-82.
Score: 0.017
-
Consensus statements from the Second International Lung Cancer Molecular Biomarkers Workshop: a European strategy for developing lung cancer molecular diagnostics in high risk populations. Int J Oncol. 2002 Aug; 21(2):369-73.
Score: 0.011
-
Expression of surfactant-associated protein in non-small-cell lung cancer: a discriminant between biologic subsets. J Natl Cancer Inst Monogr. 1992; (13):61-6.
Score: 0.005